Effects of Neonatal Fluvoxamine Administration on the Physical Development and Activity of the Serotoninergic System in White Rats

Cover Page

Abstract


Selective serotonin reuptake inhibitors (SSRIs), including fluvoxamine, are widely used to treat depressive disorders in pregnant women. These antidepressants effectively penetrate through the placental barrier, affecting the fetus during the critical phase of neurodevelopment. Some clinical studies have linked prenatal exposure to SSRIs with increased neonatal mortality, premature birth, decreased fetal growth and delay in psychomotor development. However, the effects of prenatal exposure to SSRIs remain unknown. The administration of SSRIs in rodents during the first postnatal weeks is considered as an model for studying the effects of prenatal SSRIs exposure in human. The aim of this work was to study the acute effects of chronic fluvoxamine (FA) administration in white rat pups. The study was carried out in male and female rat pups treated with FA (10 mg/kg/day, intraperitoneally) from postnatal days 1 to 14. The lethality level, body weight, age of eye opening, and motor reflex maturation were recorded. The contents of biogenic amines and their metabolites in different brain structures were also determined. It was shown that neonatal FA administration led to increased lethality level, reduced body weight, and delayed maturation of motor reflexes. Furthermore, increased noradrenalin level in hypothalamus, serotonin level in hippocampus and serotonin metabolite 5-HIAA level in frontal cortex, hypothalamus, hippocampus, and striatum were observed in drug-treated animals compared to the control group. We can conclude that the altered activity of the serotoninergic system induced by fluvoxamine administration at early developmental stages leads to a delay in physical and motor development.


N. Yu. Glazova

Institute of Molecular Genetics, Russian Academy of Sciences

Author for correspondence.
Email: nglevitskaya@gmail.com

Russian Federation

S. A. Merchieva

Lomonosov State University

Email: nglevitskaya@gmail.com

Russian Federation

M. A. Volodina

Lomonosov State University

Email: nglevitskaya@gmail.com

Russian Federation

E. A. Sebentsova

Institute of Molecular Genetics, Russian Academy of Sciences

Email: nglevitskaya@gmail.com

Russian Federation

D. M. Manchenko

Lomonosov State University

Email: nglevitskaya@gmail.com

Russian Federation

V. S. Kudrun

Institute of Pharmacology

Email: nglevitskaya@gmail.com

Russian Federation

N. G. Levitskaya

Institute of Molecular Genetics, Russian Academy of Sciences

Email: nglevitskaya@gmail.com

Russian Federation

  1. Yonkers K.A., Wisner K.L., Stewart D.E., Oberlander T.F., Dell D.L., Stotland N., Ramin S., Chaudron L., Lockwood C. // Gen. Hosp. Psychiatry. 2009, V.31, №5, P.403-413
  2. Diav-Citrin O., Ornoy A. // Obstet. Gynecol. 2012, V.2012, №ID 698947
  3. Smith M.V., Sung A., Shah B., Mayes L., Klein D.S., Yonkers K.A. // Early Hum. Dev. 2013, V.89, №2, P.81-86
  4. Haskell S.E., Hermann G.M., Reinking B.E., Volk K.A., Peotta V.A., Zhu V., Roghair R.D. // Pediatr. Res. 2013, V.73, №3, P.286-293
  5. Tuccori M., Testi A., Antonioli L., Fornai M., Montagnani S., Ghisu N., Colucci R., Corona T., Blandizzi C., Del Tacca M. // Clin. Ther. 2009, V.31, P.1426-1453
  6. Casper R.C., Gilles A.A., Fleisher B.E., Baran J., Enns G., Lazzeroni L.C. // Psychopharmacology. 2011, V.217, P.211-219
  7. Rampono J., Simmer K., Ilett K.F., Hackett L.P., Doherty D.A., Elliot R., Kok C.H., Coenen A., Forman T. // Pharmacopsychiatry. 2009, V.42, P.95-100
  8. Gentile S., Galbally M. // J. Affect. Disord. 2011, V.128, №1-2, P.1-9
  9. Altamura A.C., De Gaspari I.F., Rovera C., Colombo E.M., Mauri M.C., Fedele L. // Hum. Psychopharmacol. 2013, V.28, №1, P.25-28
  10. Jimenez-Solem E., Andersen J.T., Petersen M., Broedbaek K., Lander A.R., Afzal S., Torp-Pedersen C., Poulsen H.E. // Am. J. Psychiatry. 2013, V.170, №3, P.299-304
  11. Domar A.D., Moragianni V.A., Ryley D.A., Urato A.C. // Hum. Reprod. 2013, V.28, №1, P.160-171
  12. Casper R.C., Fleisher B.E., Lee-Ancajas J.C., Gilles A.A., Gaylor E., Debattista A., Houme H. // J. Pediatr. 2003, V.42, P.402-408
  13. Olivier J.D.A., Blom T., Arentsen T., Homberg J.R. // Progress Neuropsychopharmacol. Biol. Psychiatry. 2011, V.35, P.1400-1408
  14. Harris S.S., Maciag D., Simpson K.L., Lin R.C.S., Paul I.A. // Brain Res. 2012, V.1429, P.52-60
  15. Homberg J.R., Schubert D., Gaspar P. // Trends Pharmacol. Sci. 2010, V.31, №2, P.60-65
  16. Semple B.D., Blomgren K., Gimlin K., Ferriero D.M., Noble-Haeusslein L.J. // Prog. Neurobiol. 2013, V.106-107, P.1-16
  17. Lee L.J., Lee L. J.-H. // Developmental Neurobiol. 2012, V.72, №8, P.1122-1132
  18. Karpova N.N., Lindholm J., Pruunsild P., Timmusk T., Castrén E. // Eur. Neuropsychopharmacology. 2009, V.19, P.97-108
  19. Deiró T.C., Manhães-de-Castro R., Cabral-Filho J.E., Barreto-Medeiros J.M., Souza S.L., Marinho S.M., Castro F.M., Toscano A.E., Jesus-Deiró R.A., Barros K.M. // Physiol. Behav. 2006, V.87, №2, P.338-344
  20. Deiró T.C., Carvalho J., Nascimento E., Medeiros J.M., Cajuhi F., Ferraz-Pereira K.N., Manhães-de-Castro R. // Arq. Neuropsiquiatr. 2008, V.66, №3-B, P.736-740
  21. Hrdina P.D. // J. Psychiatry Neurosci. 1991, V.16, №2, P.10-18
  22. Kummet G.J., Haskell S.E., Hermann G.M., Ni C., Volk K.A., Younes A.K., Miller A.K., Roghair R.D. // J. Nutr. Metab. 2012, V.ID 431574
  23. Halford J.C., Blundell J.E. // Prog. Drug Res. 2000, V.54, P.25-58
  24. Lauder J.M., Tamir H., Sadler T.W. // Development. 1988, V.102, P.709-720
  25. Bakke J.L., Lawrence N.L., Robinson S.A., Bennett J., Bowers C. // Neuroendocrinology. 1978, V.25, №5, P.291-302
  26. Lopes de Souza S., Nogueira M.I., Bomfim de Jesus Deiro T.C., Manhaes de Castro F.M., Mendes da Silva C., Cesiana da Silva M., Oliveira de Lira L., Azmitia E.C., Manhaes de Castro R. // Physiol. Behav. 2004, V.82, P.375-379
  27. Mendes-da-Silva C., Goncalves L., Manhaes-de-Castro R., Nogueira M.I. // Neurosci. Let. 2010, V.483, P.179-183
  28. Kinast K., Peeters D., Kolk S.M., Schubert D., Homberg J.R. // Front. Cell. Neurosci. 2013, V.7, №72
  29. Mesquita A.R., Pego J.M., Summavielle T., Maciel P., Almeida O. F. X., Sousa N. // Neurosci. 2007, V.147, P.1022-1033
  30. Renoir T. // Front. Pharmacol. 2013, V.4, №45, P.2-10
  31. Stenfors C., Ross S.B. // Life Sci. 2002, V.71, №24, P.2867-2880
  32. Bosker F.J., Tanke M.A., Jongsma M.E., Cremers T.I., Jagtman E., Pietersen C.Y., van der Hart M.G., Gladkevich A.V., Kema I.P., Westerink B.H. // Neurochem. Int. 2010, V.57, №8, P.948-957
  33. Trouvin J.H., Gardier A.M., Chanut E., Pages N., Jacquot C. // Life Sci. 1993, V.52, №18, P.187-192
  34. Stephansson O., Kieler H., Haglund B., Artama M., Engeland A., Furu K., Gissler M., Norgaard M., Nielsen R.B., Zoega H. // JAMA. 2013, V.309, №1, P.48-54

Views

Abstract - 210

PDF (English) - 78

PDF (Russian) - 54

Cited-By


PlumX

Dimensions

Refbacks

  • There are currently no refbacks.

Copyright (c) 2014 Glazova N.Y., Merchieva S.A., Volodina M.A., Sebentsova E.A., Manchenko D.M., Kudrun V.S., Levitskaya N.G.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies